<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>French BioBeach &#187; Latests News and Alerts</title>
	<atom:link href="http://www.frenchbiobeach.com/category/alerts/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.frenchbiobeach.com</link>
	<description>Networking beyond borders</description>
	<lastBuildDate>Sat, 24 Jul 2010 07:04:06 +0000</lastBuildDate>
	<generator>http://wordpress.org/?v=2.8.4</generator>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
			<item>
		<title>Celgene to buy Abraxis for $2.9B in biotech deal</title>
		<link>http://www.frenchbiobeach.com/2010/celgene-buy-abraxis-29b-biotech-deal/</link>
		<comments>http://www.frenchbiobeach.com/2010/celgene-buy-abraxis-29b-biotech-deal/#comments</comments>
		<pubDate>Tue, 13 Jul 2010 01:09:23 +0000</pubDate>
		<dc:creator>French BioBeach</dc:creator>
				<category><![CDATA[Latests News and Alerts]]></category>

		<guid isPermaLink="false">http://www.frenchbiobeach.com/?p=3010</guid>
		<description><![CDATA[By MARLEY SEAMAN
AP Health Writer
NEW YORK (AP) &#8211; Biotechnology company Celgene said Wednesday it is expanding its array of cancer treatments with a deal to buy Abraxis BioScience Inc. for $2.9 billion in cash and stock.
Celgene Corp. said thetransaction could add $1 billion to its annual sales by 2015. The company is hoping it will [...]]]></description>
		<wfw:commentRss>http://www.frenchbiobeach.com/2010/celgene-buy-abraxis-29b-biotech-deal/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>New call for proposals planned to be published on 20 July 2010 &#8211; ERC Starting Grants</title>
		<link>http://www.frenchbiobeach.com/2010/call-proposals-planned-published-20-july-2010-erc-starting-grants/</link>
		<comments>http://www.frenchbiobeach.com/2010/call-proposals-planned-published-20-july-2010-erc-starting-grants/#comments</comments>
		<pubDate>Fri, 09 Jul 2010 23:32:24 +0000</pubDate>
		<dc:creator>French BioBeach</dc:creator>
				<category><![CDATA[Latests News and Alerts]]></category>

		<guid isPermaLink="false">http://www.frenchbiobeach.com/?p=3002</guid>
		<description><![CDATA[This grant competition is targeted at early-career research leaders, of any age, with 2-12 years of experience after their PhD. The researchers can be of any nationality as long as they are working, or moving to work, in Europe.
The competition is open to proposals in any field of research (from Socials Sciences and Humanities to [...]]]></description>
		<wfw:commentRss>http://www.frenchbiobeach.com/2010/call-proposals-planned-published-20-july-2010-erc-starting-grants/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Office of Science Announces the Early Career Research Program for FY 2011</title>
		<link>http://www.frenchbiobeach.com/2010/office-science-announces-early-career-research-program-fy-2011/</link>
		<comments>http://www.frenchbiobeach.com/2010/office-science-announces-early-career-research-program-fy-2011/#comments</comments>
		<pubDate>Wed, 07 Jul 2010 00:39:45 +0000</pubDate>
		<dc:creator>French BioBeach</dc:creator>
				<category><![CDATA[Latests News and Alerts]]></category>

		<guid isPermaLink="false">http://www.frenchbiobeach.com/?p=2998</guid>
		<description><![CDATA[Source: http://www.science.doe.gov/News_Information/News_Room/2010/July%201_EarlyCareer.html
WASHINGTON, DC – The U.S. Department of Energy (DOE) announced today it is accepting proposals for the second year of the DOE Office of Science Early Career Research Program to support the research of outstanding scientists early in their careers.  Up to $15 million in funding will be awarded in 2011 to support [...]]]></description>
		<wfw:commentRss>http://www.frenchbiobeach.com/2010/office-science-announces-early-career-research-program-fy-2011/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Arena Pharma, Eisai to Sell Obesity Drug</title>
		<link>http://www.frenchbiobeach.com/2010/arena-pharma-eisai-sell-obesity-drug/</link>
		<comments>http://www.frenchbiobeach.com/2010/arena-pharma-eisai-sell-obesity-drug/#comments</comments>
		<pubDate>Thu, 01 Jul 2010 22:09:59 +0000</pubDate>
		<dc:creator>French BioBeach</dc:creator>
				<category><![CDATA[Latests News and Alerts]]></category>

		<guid isPermaLink="false">http://www.frenchbiobeach.com/?p=2988</guid>
		<description><![CDATA[source: http://online.wsj.com/article/SB10001424052748703571704575340880052218588.html
NEW YORK—Arena Pharmaceuticals Inc. signed a deal for Japanese drug maker Eisai Co. to sell experimental weight-loss drug lorcaserin in the U.S., if it is approved by the Food and Drug Administration. 
The deal, the value of which largely rests upon the commercial success of lorcaserin, came earlier than expected as investors await the [...]]]></description>
		<wfw:commentRss>http://www.frenchbiobeach.com/2010/arena-pharma-eisai-sell-obesity-drug/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>SD News: Sanofi-aventis To Acquire TargeGen, Inc.</title>
		<link>http://www.frenchbiobeach.com/2010/sd-news-sanofiaventis-acquire-targegen/</link>
		<comments>http://www.frenchbiobeach.com/2010/sd-news-sanofiaventis-acquire-targegen/#comments</comments>
		<pubDate>Thu, 01 Jul 2010 21:11:56 +0000</pubDate>
		<dc:creator>French BioBeach</dc:creator>
				<category><![CDATA[Events News]]></category>
		<category><![CDATA[Latests News and Alerts]]></category>
		<category><![CDATA[Members Only]]></category>
		<category><![CDATA[Other Events]]></category>
		<category><![CDATA[Press Releases]]></category>

		<guid isPermaLink="false">http://www.frenchbiobeach.com/?p=2984</guid>
		<description><![CDATA[Source: http://www.targegen.com/news063010.htm
San Diego, CA – June 30, 2010- TargeGen, Inc., a privately held biotechnology company focused on the development of small molecule kinase inhibitors today announced that the Company has agreed to be acquired by sanofi-aventis (EURONEXT: SAN; NYSE: SNY). Under the agreement, the ultimate purchase price will depend on the achievement of certain future [...]]]></description>
		<wfw:commentRss>http://www.frenchbiobeach.com/2010/sd-news-sanofiaventis-acquire-targegen/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>One in four firms not complying with chemical legislation</title>
		<link>http://www.frenchbiobeach.com/2010/firms-complying-chemical-legislation/</link>
		<comments>http://www.frenchbiobeach.com/2010/firms-complying-chemical-legislation/#comments</comments>
		<pubDate>Tue, 08 Jun 2010 18:57:06 +0000</pubDate>
		<dc:creator>French BioBeach</dc:creator>
				<category><![CDATA[Doing Business with France]]></category>
		<category><![CDATA[Latests News and Alerts]]></category>
		<category><![CDATA[Press Releases]]></category>

		<guid isPermaLink="false">http://www.frenchbiobeach.com/?p=2979</guid>
		<description><![CDATA[Inspection data suggests that a quarter of chemical companies have not been complying with European chemicals legislation.
]]></description>
		<wfw:commentRss>http://www.frenchbiobeach.com/2010/firms-complying-chemical-legislation/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Bayer names ex-Novartis manager as HealthCare boss</title>
		<link>http://www.frenchbiobeach.com/2010/bayer-names-exnovartis-manager-healthcare-boss/</link>
		<comments>http://www.frenchbiobeach.com/2010/bayer-names-exnovartis-manager-healthcare-boss/#comments</comments>
		<pubDate>Wed, 21 Apr 2010 15:29:23 +0000</pubDate>
		<dc:creator>French BioBeach</dc:creator>
				<category><![CDATA[Latests News and Alerts]]></category>

		<guid isPermaLink="false">http://www.frenchbiobeach.com/?p=2974</guid>
		<description><![CDATA[Former Novartis COO Joerg Reinhardt to head HealthCare
Healthcare
* Reinhardt replaces Arthur Higgins, who leaves on April 30
* Reinhardt once tipped as possible Novartis CEO successor
* Bayer shares rise 0.5 percent
(Writes through, adds detail)
FRANKFURT, April 21 (Reuters) &#8211; Bayer (BAYGn.DE) named former Novartis (NOVN.VX) manager Joerg Reinhardt to head its burgeoning health care division, bringing in [...]]]></description>
		<wfw:commentRss>http://www.frenchbiobeach.com/2010/bayer-names-exnovartis-manager-healthcare-boss/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Marie Curie International Research Staff Exchange Scheme (IRSES)</title>
		<link>http://www.frenchbiobeach.com/2010/marie-curie-international-research-staff-exchange-scheme-irses/</link>
		<comments>http://www.frenchbiobeach.com/2010/marie-curie-international-research-staff-exchange-scheme-irses/#comments</comments>
		<pubDate>Thu, 04 Mar 2010 01:50:06 +0000</pubDate>
		<dc:creator>French BioBeach</dc:creator>
				<category><![CDATA[Career]]></category>
		<category><![CDATA[Doing Business with France]]></category>
		<category><![CDATA[Latests News and Alerts]]></category>
		<category><![CDATA[Members Only]]></category>
		<category><![CDATA[Press Releases]]></category>

		<guid isPermaLink="false">http://www.frenchbiobeach.com/?p=2952</guid>
		<description><![CDATA[The Marie Curie International Research Staff Exchange Scheme in the People program of FP7 aims at strengthening research partnership through short staff exchanges and networking between European research organizations and organizations in Third Countries (such as the United States). This funding is open to all domains of research, except for the areas covered by the [...]]]></description>
		<wfw:commentRss>http://www.frenchbiobeach.com/2010/marie-curie-international-research-staff-exchange-scheme-irses/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>March 16th &#8211; FABS: French American Biotech Symposium</title>
		<link>http://www.frenchbiobeach.com/2010/fabs3/</link>
		<comments>http://www.frenchbiobeach.com/2010/fabs3/#comments</comments>
		<pubDate>Mon, 22 Feb 2010 02:14:17 +0000</pubDate>
		<dc:creator>French BioBeach</dc:creator>
				<category><![CDATA[Doing Business with France]]></category>
		<category><![CDATA[Events News]]></category>
		<category><![CDATA[French BioBeach Events]]></category>
		<category><![CDATA[Latests News and Alerts]]></category>
		<category><![CDATA[Members Only]]></category>
		<category><![CDATA[Contact]]></category>
		<category><![CDATA[Event]]></category>
		<category><![CDATA[France]]></category>
		<category><![CDATA[Research]]></category>
		<category><![CDATA[Salk]]></category>
		<category><![CDATA[San Diego]]></category>

		<guid isPermaLink="false">http://www.frenchbiobeach.com/2010/the-fabs-french-american-biotech-symposium/</guid>
		<description><![CDATA[Title: March 16th &#8211; FABS: French American Biotech SymposiumLocation: The Salk Instittute for Biological StudiesDescription: The FABS (French American Biotechnology Symposium) is a scientific seminar devoted to New Therapeutic and Vaccine Approaches to Infectious Diseases.
Start Time: 08:30 AM
Date: 2010-03-16
The objective is to promote cooperation in science and technology between the US and France. 
The FABS [...]]]></description>
		<wfw:commentRss>http://www.frenchbiobeach.com/2010/fabs3/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>March 15th &#8211; FBT: French Biotech Tour California</title>
		<link>http://www.frenchbiobeach.com/2010/fbt/</link>
		<comments>http://www.frenchbiobeach.com/2010/fbt/#comments</comments>
		<pubDate>Mon, 22 Feb 2010 02:09:09 +0000</pubDate>
		<dc:creator>French BioBeach</dc:creator>
				<category><![CDATA[Events News]]></category>
		<category><![CDATA[French BioBeach Events]]></category>
		<category><![CDATA[Latests News and Alerts]]></category>
		<category><![CDATA[Members Only]]></category>
		<category><![CDATA[Business]]></category>
		<category><![CDATA[Contact]]></category>
		<category><![CDATA[Event]]></category>
		<category><![CDATA[Events]]></category>
		<category><![CDATA[France]]></category>
		<category><![CDATA[French BioBeach]]></category>
		<category><![CDATA[Salk]]></category>
		<category><![CDATA[San Diego]]></category>

		<guid isPermaLink="false">http://www.frenchbiobeach.com/2010/french-biotech-tour-california-fbt/</guid>
		<description><![CDATA[Title: March 15th &#8211; FBT: French Biotech Tour CaliforniaLocation: The Salk Institute for Biological StudiesLink out: Click here
Start Time: 08:00Date: 2010-02-15
Description: The French Biotech Tour California (FBT) is a US/French partnering event with a focus on infectious diseases. The event will consist of the following:
+ US and French company presentations
+ Pre-booked, validated one-to-one meetings (30 [...]]]></description>
		<wfw:commentRss>http://www.frenchbiobeach.com/2010/fbt/feed/</wfw:commentRss>
		<slash:comments>2</slash:comments>
		</item>
	</channel>
</rss>
